COVID-Vaccinated Who Receive 4 Doses 'More Likely to Become Infected Than People Who Received Fewer Vaccinations': European Journal of Clinical Investigation
“Individuals with repeated previous infections had reduced re-infection risk."
A November study published in the European Journal of Clinical Investigation found that SARS-CoV-2 infection risk was higher in those who received four vaccinations compared to less vaccinated individuals.
Among 3,986,312 previously infected individuals in Australia, 281,291 (7.1%) had four and 1,545,242 (38.8%) had three vaccinations at baseline, according to the study.
The authors recorded 69 COVID deaths and 89,056 SARS-CoV-2 infections.
The risk of infection for four versus three vaccine doses “rapidly diminished over time” and “infection risk with four vaccinations was higher compared to less vaccinated individuals during extended follow-up until June 2023,” the study confirms.
Less vaccinated groups showed “significantly lower SARS-CoV-2 infection risk compared to the four vaccine dose group in 2023.”
In fact, it was those who had been previously been infected with the disease who had a reduced risk of re-infection:
“Individuals with repeated previous infections had reduced re-infection risk,” the authors state. “Repeated previous and more recent SARS-CoV-2 infections were both associated with significantly reduced reinfections.”
The study authors conclude by questioning the recommendation for repeat COVID vaccinations and emphasize the drug’s “diminishing effectiveness”:
“In general, our study results question whether recommendations for repeated vaccine boosters against SARS-CoV-2 are currently justified for large parts of the general population with a history of previous infections,” they write. “Our findings fit well to the hypothesis of diminishing effectiveness and thus shifting risk–benefit ratios from additional vaccinations during the transition of the COVID-19 pandemic to its endemic phase.”
A letter to the editor published in the same journal confirmed the study demonstrated that “people who received 4 doses were more likely to become infected than people who received fewer vaccinations.”
You can download the full study below:
In February 2023, new research published in The Lancet confirmed that natural immunity acquired from a coronavirus infection can provide strong and long-lasting protection against severe illness and death.
The study signified the largest meta-analysis to date on immunity following infection, analyzing data from 65 studies in 19 countries.
The paper found that, for all variants, infection-acquired immunity reduced the risk of hospitalization and death from a COVID reinfection by 88.9% for at least 10 months.
“Protection from past infection against re-infection from pre-omicron variants was very high and remained high even after 40 weeks,” the authors wrote.
The study authors concluded that the “high” immunity gained by past infection “should be weighed alongside” pharmaceutical methods of preventing COVID infection, such as those recommended by Dr. Fauci and Johns Hopkins.
However, the authors emphasized that natural immunity could even be “higher” than those other methods.
“[O]ur analysis of the available data suggests that the level of protection afforded by previous infection is at least as high, if not higher than that provided by two-dose vaccination using high-quality mRNA vaccines (Moderna and Pfizer-BioNTech),” the authors stated.
Hi Jon, can you send me the study, or paper you spoke of on Alex's show today regarding Budesonide? Thank you.